These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21907808)

  • 21. Discovery of the First Highly Selective Antagonist of the GluK3 Kainate Receptor Subtype.
    Chałupnik P; Vialko A; Pickering DS; Hinkkanen M; Donbosco S; Møller TC; Jensen AA; Nielsen B; Bay Y; Kristensen AS; Johansen TN; Łątka K; Bajda M; Szymańska E
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zinc potentiates GluK3 glutamate receptor function by stabilizing the ligand binding domain dimer interface.
    Veran J; Kumar J; Pinheiro PS; Athané A; Mayer ML; Perrais D; Mulle C
    Neuron; 2012 Nov; 76(3):565-78. PubMed ID: 23141068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping the ligand binding sites of kainate receptors: molecular determinants of subunit-selective binding of the antagonist [3H]UBP310.
    Atlason PT; Scholefield CL; Eaves RJ; Mayo-Martin MB; Jane DE; Molnár E
    Mol Pharmacol; 2010 Dec; 78(6):1036-45. PubMed ID: 20837679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tritium and deuterium labelling of a kainate receptor antagonist and evaluation as a radioligand.
    Chałupnik P; Marek A; Hovah MEL; Pickering DS; Temperini P; Donbosco S; Szymańska E; Johansen TN
    J Labelled Comp Radiopharm; 2024 Apr; 67(4):120-130. PubMed ID: 38332677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms for ligand binding to GluR0 ion channels: crystal structures of the glutamate and serine complexes and a closed apo state.
    Mayer ML; Olson R; Gouaux E
    J Mol Biol; 2001 Aug; 311(4):815-36. PubMed ID: 11518533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structure of a glutamate/aspartate binding protein complexed with a glutamate molecule: structural basis of ligand specificity at atomic resolution.
    Hu Y; Fan CP; Fu G; Zhu D; Jin Q; Wang DC
    J Mol Biol; 2008 Sep; 382(1):99-111. PubMed ID: 18640128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of homomeric and heteromeric kainate receptors by the auxiliary subunit Neto1.
    Fisher JL; Mott DD
    J Physiol; 2013 Oct; 591(19):4711-24. PubMed ID: 23798491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding mode of an α-amino acid-linked quinoxaline-2,3-dione analogue at glutamate receptor subtype GluK1.
    Demmer CS; Møller C; Brown PM; Han L; Pickering DS; Nielsen B; Bowie D; Frydenvang K; Kastrup JS; Bunch L
    ACS Chem Neurosci; 2015 Jun; 6(6):845-54. PubMed ID: 25856736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural dynamics of an ionotropic glutamate receptor.
    Kubo M; Ito E
    Proteins; 2004 Aug; 56(3):411-9. PubMed ID: 15229875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (
    Poulie CBM; Larsen Y; Leteneur C; Barthet G; Bjørn-Yoshimoto WE; Malhaire F; Nielsen B; Pin JP; Mulle C; Pickering DS; Bunch L
    ACS Chem Neurosci; 2022 May; 13(10):1580-1587. PubMed ID: 35475632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subtype selectivity and flexibility of ionotropic glutamate receptors upon antagonist ligand binding.
    Pentikäinen U; Settimo L; Johnson MS; Pentikäinen OT
    Org Biomol Chem; 2006 Mar; 4(6):1058-70. PubMed ID: 16525550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal structure of the GluR0 ligand-binding core from Nostoc punctiforme in complex with L-glutamate: structural dissection of the ligand interaction and subunit interface.
    Lee JH; Kang GB; Lim HH; Jin KS; Kim SH; Ree M; Park CS; Kim SJ; Eom SH
    J Mol Biol; 2008 Feb; 376(2):308-16. PubMed ID: 18164033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlating efficacy and desensitization with GluK2 ligand-binding domain movements.
    Nayeem N; Mayans O; Green T
    Open Biol; 2013 May; 3(5):130051. PubMed ID: 23720540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural dynamics of the GluK3-kainate receptor neurotransmitter binding domains revealed by cryo-EM.
    Kumari J; Bendre AD; Bhosale S; Vinnakota R; Burada AP; Tria G; Ravelli RBG; Peters PJ; Joshi M; Kumar J
    Int J Biol Macromol; 2020 Apr; 149():1051-1058. PubMed ID: 32006583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural and Functional Insights into GluK3-kainate Receptor Desensitization and Recovery.
    Kumari J; Vinnakota R; Kumar J
    Sci Rep; 2019 Jul; 9(1):10254. PubMed ID: 31311973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rational design, synthesis and pharmacological evaluation of the (2R)- and (2S)-stereoisomers of 3-(2-carboxypyrrolidinyl)-2-methyl acetic acid as ligands for the ionotropic glutamate receptors.
    Rasmussen JL; Storgaard M; Pickering DS; Bunch L
    ChemMedChem; 2011 Mar; 6(3):498-504. PubMed ID: 21268287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical functional properties of GluK3-containing kainate receptors.
    Perrais D; Coussen F; Mulle C
    J Neurosci; 2009 Dec; 29(49):15499-510. PubMed ID: 20007474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of kainate receptor subunit ratios in mouse brain using novel chimeric protein standards.
    Watanabe-Iida I; Konno K; Akashi K; Abe M; Natsume R; Watanabe M; Sakimura K
    J Neurochem; 2016 Jan; 136(2):295-305. PubMed ID: 26448475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological activity of C10-substituted analogs of the high-affinity kainate receptor agonist dysiherbaine.
    Lash-Van Wyhe LL; Postila PA; Tsubone K; Sasaki M; Pentikäinen OT; Sakai R; Swanson GT
    Neuropharmacology; 2010 Mar; 58(3):640-9. PubMed ID: 19962997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligand-binding characteristics and related structural features of the expressed goldfish kainate receptors: identification of a conserved disulfide bond and three residues important for ligand binding.
    Wo ZG; Oswald RE
    Mol Pharmacol; 1996 Oct; 50(4):770-80. PubMed ID: 8863821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.